Enter assignee name

EPO Patents = 1

Forward Citations = 30

Loading Chart...

10 inventors (with patents filed for the assignee):

Jens Pohl (3 out of 23 patents)

Michael Paulista (3 out of 11 patents)

Rolf Bechtold (2 out of 15 patents)

4. Klaus Unsicker (2 out of 3 patents)

5. Jun Honda (1 out of 15 patents)

6. Hidetoshi Andou (1 out of 2 patents)

7. Gertrud Hötten (1 out of 8 patents)

8. Gertrud Hötten (1 out of 4 patents)

9. Sjunjiro Sugimoto (1 out of 1 patent)

10. Takeyuki Sugiura (1 out of 3 patents)

11. Dirk Grafahrend (4 patents)

12. Daniel Neumüller (3 patents)

13. Denis Reibel (8 patents)

14. Frank Plöger (4 patents)

5 patents: Sort by Forward Citations

1. 7632808 - Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system (2009-12-15),

2. 7479279 - Use of cytokines of the TGF-β superfamily for the treatment, inhibition and/or diagnosis of skin related disorders (2009-01-20),

3. 6551801 - Process for preparing purified dimer of bone-derived factor (2003-04-22),

4. 6531450 - Use of MP52 or MP121 for treating and preventing diseases of the nervous system (2003-03-11),

5. 6475735 - Human BMP-2 promoter and method for exploring bone-related substance by using the same (2002-11-05),

Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka is a leading biotechnology company specializing in the development of pharmaceuticals. With a focus on innovative research and cutting-edge technology, Biopharm is dedicated to advancing the field of biopharmaceuticals and improving patient outcomes. Through strategic partnerships and collaborations, Biopharm continues to drive advancements in drug development and delivery, with a commitment to quality and safety.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#57 in Heidelberg

#6,003 in Germany

Heidelberg, Germany

Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka